ArticleClinical and translational medicine2022

Single-cell profiling-guided combination therapy of c-Fos and histone deacetylase inhibitors in diffuse large B-cell lymphoma.

Luqiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.